SU2C is making $7.5 million in research grants available to early-career scientists who are pursuing innovative cancer research projects focusing on immuno-oncology, the American Association for Cancer Research said. Funded by a grant Bristol-Myers Squibb Co. a total of 10 Innovative Research Grants will be available, each up to $750,000, over three years. The IRG...
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
